We recently compiled a list of the 10 Cash-Rich Mid Cap Stocks To Buy Now. In this article, we are going to take a look at ...
SON Xperiences, a global leader in AI-driven customer experience (CX) solutions with a presence in 22 countries, has announced a strategic partnership with Aistra, an AI Adoption company, focusing on ...
The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...
Zacks Investment Research on MSN13h
HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip?Hologic HOLX stock has been experiencing a declining trend as it navigates an evolving geopolitical and macroeconomic landscape. The shares of the Marlborough, MA-based women’s health company have ...
QIAGEN has received FDA approval for its QIAstat-Dx Gastrointestinal Panel 2 Mini B, expanding its syndromic testing offerings for gastrointestin ...
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A. (EPA: BIM) for patent in ...
Qiagen (QGEN) announced that it has filed a complaint against bioMerieux for patent infringement. The complaint, filed in the Local Division of ...
AI agents are the next frontier of AI assistants, going beyond answering questions to performing tasks. Qualtrics is ...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, further ...
Qiagen N.V., a Netherlands-based medical diagnostics provider, faces market pressure due to some recent NIH funding concerns, despite strong financials and a diverse product portfolio. The company ...
Qiagen (QGEN) announced that the FDA has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use. This marks Qiagen’s second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback